Multifilament/Braided Absorbable Sutures Market Size, Share & Industry Analysis, By Type (Natural and Synthetic), By Application (Gynecology, Orthopedics, Cardiology, General Surgery, and Others), By End-user (Hospitals & ASCs, Specialty Clinics, and Others), and Regional Forecast, 2025-2032

The global multifilament/braided absorbable sutures market size was valued at USD 3.04 billion in 2024. The market is projected to grow from USD 3.20 billion in 2025 to USD 5.51 billion by 2032, exhibiting a CAGR of 8.0% during the forecast period. North America dominated the multifilament/braided absorbable sutures market with a market share of 42.76% in 2024. 

Multifilament/braided absorbable sutures are surgical threads made of multiple strands, twisted or braided together, that are designed to be absorbed by the body over time. These types of sutures are either made of natural or synthetic materials, and they do not require removal by a doctor, making them ideal for internal wounds or surgical sites that are difficult to access after surgery. They offer higher tensile strength and flexibility compared to monofilament sutures.

The high burden of chronic diseases and an increase in the number of surgical procedures generate demand for surgical solutions, thereby enhancing market growth.

• For example, as per the data provided by the Journal of Orthopedic Case Reports in July 2024, in India, around 16,308 joint replacements were performed in 2020, which increased to 17,440 in 2021.

The DemeTECH Corporation, Johnson & Johnson Services, Inc., Medtronic, and B. Braun SE are some of the major players operating in the market. These companies strongly focus on growth strategies such as new product launches to gain a significant portion of the global market.

MARKET DYNAMICS

Market Drivers:

Rise in Surgical Procedures to Enhance Demand for Multifilament Absorbable Sutures Globally

The increasing number of surgical procedures, including orthopedic surgeries, gynecological surgeries, and cosmetic procedures worldwide, is fueling the demand for multifilament/braided resorbable sutures. These sutures are preferred for their ability to facilitate rapid wound closure and promote efficient tissue healing, thereby contributing to the market growth.

• For example, according to data published by the International Society of Aesthetic Plastic Surgery in June 2024, around 0.9 million rhinoplasty procedures were performed worldwide in 2022. This number was increased to 1.1 million in 2023.
• Also, as per the data provided by the GOV.U.K., in May 2024, in the U.K., nearly 34.7% deliveries were performed by caesarean section in 2022, which increased to 37.8% in 2023.

Additionally, the growing geriatric population is more prone to chronic conditions, leading to the rising number of surgeries. This results in increasing usage of sutures during surgical procedures, thereby supplementing market growth.

Market Restraints:

Rising Adoption of Alternative Solutions Hamper Market Growth

The growing preference among healthcare providers for alternative wound closure methods is hampering the adoption of multifilament/braided dissolvable sutures. Alternative methods, such as tissue adhesives, surgical staplers, and hemostats, are mostly preferred in specific surgical procedures due to their notable benefits, such as rapid application, reduced tissue trauma, and improved surgical outcomes.

Furthermore, surgical staplers are widely utilized in laparotomy and orthopedic surgeries for their efficiency and speed. On the other hand, tissue adhesives are gaining popularity in dermatological and cosmetic procedures to minimize scarring. These alternative methods limit the adoption of multifilament/braided sutures in various clinical settings worldwide.

• For instance, according to data published by the Suture Planet in February 2025, surgical staplers offer several advantages over surgical sutures, including faster application, stronger & secure closure, and minimal tissue damage.
• Similarly, as per the data provided by Unisur Lifecare in October 2024, skin staplers have a shorter operating time; hence, they are more preferred than sutures. Staplers are also commonly used to close injuries quickly, especially in emergencies, rather than sutures.

Thus, the rising shift of patients toward alternatives to surgical sutures, such as surgical staplers, adhesive tapes, and tissue sealants, is anticipated to hinder market expansion in the upcoming years.

Market Opportunities:

Growing Healthcare Infrastructure in Developing Nations Creates a Significant Growth Opportunity

Expanding healthcare infrastructure in developing countries creates opportunities for the multifilament/braided absorbable sutures market to grow. As the healthcare infrastructure expands, the number of surgical procedures will increase. This results in an increasing demand for advanced wound closure solutions.

Additionally, establishing new hospitals and rising alliances between hospitals and clinics, particularly in developing nations, enhance the global multifilament/braided absorbable sutures market growth. This expansion increases the volume of surgical procedures, creating a greater demand for sutures. For example, in June 2025, Griffith Base Hospital opened in New South Wales, Australia.

Furthermore, the increasing aging population, rising prevalence of chronic diseases, and advancements in suture technology, including antimicrobial coatings and sutures for knotless closure, are some of the additional factors creating substantial opportunities for market growth.

Market Challenges:

Post-operative Complications of Sutures Affect its Adoption and Market Growth

Despite an important role of multifilament or braided absorbable sutures in wound closure, they can sometimes lead to post-surgical complications such as suture-associated infection, wound dehiscence (reopening of a wound after it has been sutured), suture knot failure, scarring, suture-associated hypersensitivity reactions, and tissue reactions such as granuloma formation. These post-surgical complications are significant challenges hindering the market growth. These complications can lead to increased patient morbidity, higher healthcare costs, and a reluctance to adopt these sutures in certain surgical procedures.

Due to concerns regarding post-operative complications of sutures, many healthcare providers are shifting their focus toward alternatives such as non-absorbable sutures. This change in clinical preference is projected to affect the market growth over the forecast period.

Stringent Regulatory Approval Processes are Challenging Market Growth

Regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA), require comprehensive testing and thorough documentation to verify the safety and effectiveness of medical devices, including multifilament absorbable sutures. These regulatory demands significantly impact market growth by raising development costs and causing delays in product approvals, particularly affecting smaller manufacturers with limited financial and operational resources.

Moreover, the complex, strict, and often inconsistent regulatory frameworks across different countries further hinder market expansion by creating barriers to market access.

MULTIFILAMENT/BRAIDED ABSORBABLE SUTURES MARKET TRENDS

Increasing Launch of Technologically Advanced Absorbable Sutures in the Global Market

The technological advancements in absorbable sutures, including synthetic bioengineered and antimicrobial-coated resorbable sutures, are the major market trends, supported by regulatory approvals and growing surgeon awareness of their clinical benefits.

• For example, in September 2023, Genesis MedTech secured approval from China's National Medical Products Administration (NMPA) for the market launch of its resorbable sutures with antibacterial protection.

Furthermore, the knotless absorbable sutures have been rapidly adopted in minimally invasive surgeries, where precise tension and reduced tissue trauma are critical. As a result, surgeons across the globe are increasingly favoring absorbable knotless sutures due to their ability to minimize the risk of infection, eliminate the need for suture removal, and provide consistent wound closure without the technical challenges of knot tying. These are some of the major market trends influencing market growth.

Download Free sample to learn more about this report.

SEGMENTATION ANALYSIS

By Type

Government Recommendations Regarding Usage of Synthetic Absorbable Sutures are Augmenting Segment Growth

On the basis of type, the market is categorized into natural and synthetic.

The synthetic segment is expected to dominate the market throughout the forecast period. The increasing launch of innovative synthetic multifilament/braided absorbable sutures in the global market is augmenting the segmental growth. Furthermore, the increasing government focus on promoting the usage of synthetic antibacterial sutures for surgical procedures is further supplementing the segmental growth.

• For instance, in June 2021, Ethicon, a subsidiary of Johnson & Johnson Services, Inc., announced that the National Institute for Health and Care Excellence issued new medical technologies guidance (MTG59) recommending the use of Plus antibacterial sutures in surgeries within the healthcare system of the U.K.

The natural segment is anticipated to grow considerably during the forecast period. Natural resorbable sutures, such as catgut, are made from biological materials that naturally degrade and are absorbed by the body over time. Due to their greater absorbability, these sutures are widely used in gynecological, ophthalmic, and plastic surgeries. These are some of the important factors enhancing segmental growth. Furthermore, natural sutures are less expensive than synthetic sutures, making them accessible, especially in resource-constrained settings of low and middle-income countries.

By Application

Increasing Volume of Orthopedic Surgeries to Augment Segment Growth

On the basis of application, the market is divided into gynecology, orthopedics, cardiology, general surgery, and others.

The orthopedics segment is projected to dominate the market from 2025 to 2032. The dominance of this segment is primarily due to the increasing prevalence of orthopedic disorders and the rising number of hip and knee replacement surgeries across the globe.

• For example, according to the Australian Orthopaedic Association National Joint Replacement Registry 2024 Annual Report, published in June 2024, around 146,795 hip, knee, and shoulder replacements were performed across Australia in 2023, representing a significant 16.0% increase over the previous year.

The gynecology segment is expected to grow substantially during the forecast period, owing to a rise in the number of births by cesarean section.

• For instance, according to data published by the Canadian Institute for Health Information (CIHI) in February 2024, the C-section rate in Canada was 33.4% in 2023.

The general surgery segment is projected to grow moderately during the forecast period, owing to the growing demand for multifilament/braided absorbable sutures primarily for surgeries such as cholecystectomy, appendectomy, and hysterectomy, which escalates the adoption of wound closure products.

• For example, according to data published by the Annals of the Royal College of Surgeons of England in April 2024, more than 60,000 laparoscopic cholecystectomies (LC) are performed every year in the U.K.

The cardiology segment accounted for the second-largest multifilament/braided absorbable sutures market share in 2024, owing to rising usage of resorbable sutures in cardiac surgeries, specifically during cardiopulmonary bypass.

The others segment is projected to grow considerably during the forecast period. The increasing use of multifilament/braided sutures in cosmetic surgeries drives segmental growth.

By End-user

Higher Volume of Surgical Procedures Performed at Hospitals & ASCs is Responsible for their Dominance

Based on end-user, the market is divided into hospitals & ASCs, specialty clinics, and others.

The hospitals & ASCs segment dominated the market in 2024 and is expected to grow at the highest CAGR during the forecast period. The dominance of this segment was mainly due to the higher patient preference for medical care in hospitals. Also, the rising hospitalizations for surgical procedures and advanced care have been fueling the segmental growth.

• For instance, according to the data published by the Australian Institute of Health and Welfare in December 2024, around 12,700 coronary artery bypass grafting (CABG) procedures and 43,700 percutaneous coronary interventions (PCI) were performed on patients admitted to hospital in Australia from 2021-22.

The specialty clinics segment is anticipated to grow moderately during the forecast period, owing to the opening of new specialty clinics worldwide to provide patients with specialized care for particular medical conditions.

• For instance, in October 2022, the Silesian Centre for Heart Diseases was officially opened in Zabrze, Poland.

The others segment is anticipated to grow at a considerable CAGR during the forecast period. The increasing usage of multifilament absorbable sutures at academic clinics and nursing homes for training purposes is enhancing the segmental growth.

MULTIFILAMENT/BRAIDED ABSORBABLE SUTURES MARKET REGIONAL OUTLOOK

On the basis of regions, the global market can be divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America

To get more information on the regional analysis of this market, Download Free sample

North America dominated the global market in 2024 with a market size of USD 1.30 billion and accounted for a 42.8% market share. The established healthcare infrastructure, high volume of surgical procedures across the region, and the strong demand for absorbable sutures among healthcare facilities are expected to fuel the regional market growth in the coming years.

The rising number of medical events across the U.S., which involve the participation of market players showcasing absorbable sutures, is expected to boost the country's market growth.

• For instance, in June 2025, Dolphin Sutures was present at the FIME 2025, which was held from 11^th to 13^th June 2025 in Miami Beach Convention Center, Florida, U.S. During the event, the company was present at stall no. I 83 to showcase its surgical products, including multifilament absorbable sutures, to create brand awareness among consumers.

Europe

Europe held a moderate share of the market in 2024 and is anticipated to grow at the second-highest CAGR throughout the forecast period. The rise in the number of surgeries, including cardiac surgeries, orthopedic surgeries, general surgeries, and others, is driving market growth in this region.

• For example, as per the data provided by the National Center for Biotechnology Information (NCBI) in August 2024, around 100,606 cardiac surgeries were performed in Germany in 2023.

Asia Pacific

The market in Asia Pacific is anticipated to grow at a dominant CAGR during the forecast period. The rising market players' focus on new product launches is enhancing the market growth across the region.

• For example, in August 2023, Healthium Medtech launched TRUMAS, a range of dissolvable multifilament/braided sutures in the Indian market. These sutures were designed to address challenges faced during suturing in minimal-access surgeries.

Furthermore, the expanding medical infrastructure, growing medical tourism, and increasing geriatric population susceptible to chronic diseases are further supplementing market growth in this region.

Latin America and Middle East & Africa

The market in Latin America and the Middle East & Africa is projected to grow stagnantly from 2025 to 2032. The rise in the number of surgical procedures, such as general surgeries, cardiac surgeries, orthopedic surgeries, and ophthalmic surgeries, among others, is driving market growth in these regions.

COMPETITIVE LANDSCAPE

Key Industry Players:

Emphasis of Market Players on Attending Medical Events to Create Product Awareness Among Healthcare Professionals

The market comprises key players, such as Johnson & Johnson Services, Inc., Medtronic, B. Braun SE, ORION SUTURES INDIA PVT. LTD., and DemeTECH Corporation, among others, are providing absorbable sutures worldwide. The growing focus of these companies on participating in medical events to create product awareness among healthcare professionals is one of the prominent factors contributing to their substantial position in the global market.

• For example, in November 2024, ORION SUTURES INDIA PVT. LTD. was present at the MEDICA 2024 held in Düsseldorf, Germany from 11^th to 14^th November 2024. During the event, the company showcased its all-suture products, including multifilament sutures, to create brand awareness among consumers.

The other companies operating in the market are Genesis Medtech, Dolphin Sutures, Suture Planet, Medico, and Dynek Pty Ltd. The growing focus of these key players on receiving regulatory approvals for new product launches is one of the important factors contributing to their considerable position in the global market.

List of Key Multifilament/Braided Absorbable Sutures CompaniesProfiled:

• Johnson & Johnson Services, Inc. (U.S.)
• Medtronic (Ireland)
• Braun SE (Germany)
• Healthium Medtech Limited (India)
• DemeTECH Corporation (U.S.)
• Genesis Medtech (Singapore)
• Dolphin Sutures (India)
• Lotus Surgicals Pvt Ltd (India)
• Suture Planet (India)
• Medico (China)
• Dynek Pty Ltd (Australia)
• ORION SUTURES INDIA PVT. LTD. (India)
• Unisur Lifecare (India)

KEY INDUSTRY DEVELOPMENTS:

• October 2024 - ORION SUTURES INDIA PVT. LTD. announced its presence at Africa Health 2024, a medical conference held in South Africa. During the event, the company was present at stall number H2.E17 to create awareness about its braided dissolvable stitches among consumers.
• November 2023 - Peters Surgical entered into a distribution partnership with Vertice Healthcare to expand its sutures offering across South Africa.
• September 2023 - Johnson & Johnson Services, Inc. announced that it had received the Healthcare Industry Resilience Collaborative (HIRC) Transparency Badge for its Ethicon suture products. This badge demonstrates the company's transparent and resilient supply chain for its customers.
• November 2022 - Ur24Technology Inc. entered into a strategic collaboration with DemeTECH Corporation to enhance the surgical product distribution network worldwide.
• June 2021 - Genesis Medtech announced the acquisition of Horcon, a China-based suture company. This acquisition helped the company to expand its surgical device portfolio.

REPORT COVERAGE

The global multifilament/braided absorbable sutures market report provides a detailed competitive landscape and market insights. In addition to the global market size, it covers regional analysis of different market segments, profiles of key market players, and market dynamics. Moreover, the report encompasses several factors that have contributed to the market's growth over recent years.

To gain extensive insights into the market, Download for Customization

REPORT SCOPE & SEGMENTATION